Skip to main content
. 2020 Aug 13;15(8):e0237308. doi: 10.1371/journal.pone.0237308

Fig 5. CTC isolations from metastatic breast cancer patients.

Fig 5

(A) Isolation of CTCs by RosetteSep™ and ScreenCell® methods of all patient samples (p = 0.29). (B) number of CTCs isolated by both the RosetteSep™ and ScreenCell® methods from 6 metastatic breast cancer patients (p = 0.13).